Comparison of plasma adiponectin levels in New Zealand Māori and Caucasian individuals

New Zealand Medical Journal

Volumn 120, Issue 1257, 2007, Pages

  Shand, Brett ^a   Elder, Peter ^b   Scott, Russell ^a   Poa, Nicola ^c   Frampton, Christopher M ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b CANTERBURY HEALTH LABORATORIES   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN; INSULIN; LIPID;

ADULT; AGE; ANTHROPOMETRY; ARTICLE; BLOOD GLUCOSE MONITORING; BODY BUILD; BODY COMPOSITION; BODY FAT; BODY MASS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETOGENESIS; ETHNIC DIFFERENCE; FEMALE; GENDER; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LINEAR REGRESSION ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MAORI; METABOLIC SYNDROME X; NEW ZEALAND; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS REGULATION; SMOKING HABIT; STATISTICAL SIGNIFICANCE; STUDENT T TEST; WAIST CIRCUMFERENCE; WILCOXON SIGNED RANKS TEST; BLOOD; COMPARATIVE STUDY; ETHNOLOGY; MIDDLE AGED;

ADIPONECTIN; ADULT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NEW ZEALAND;

EID: 34547119280     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to c1q, produced exclusively by adipocytes. J Biol Chem. 1995;270:26746-9.
2. Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A. 2001;98:2005-10.
3. Matsuzawa Y. Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease. Atherosclerosis Suppl. 2005;6:7-14.
4. Whitehead JP, Richards AA, ffickman U, et al. Adiponectin - a key adipolkine in the metabolic syndrome. Diabetes Obes Metab. 2006;8:264-80.
5. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation. 1999; 100:2473-6.
6. Lara-Costo C, Luo N, Wallace P, et at. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes. 2006;55:249-59.
7. Nakashima R, Kamei N, Yamane K, et al. Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab. 2006;91:3873-77.
8. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930-5.
9. Shand BI, Scott RS, Elder PA, George PM. Plasma adiponectin in overweight, non-diabetic individuals with or without insulin resistance. Diabetes Obes Metab. 2003;5:349-53.
10. Daimon M, Oizumi T, Saitoh T, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population. The Fungata study. Diabetes Care. 2003;26:2015-20.
11. Snehalatha C, Mukesh B, Simon M, et al. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care. 2003;26:3226-9.
12. Spranger J, Kroke A, Möhlig M, et al. Adiponectin and protection against type 2 diabetes. Lancet. 2003;61:226-8.
13. Yildiz BO, Suchard MA, Wong ML, et al. Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc Natl Acad Sci U S A. 2004; 101: 10434-9.
14. Shand B, Elder P, Scott R, et al. Biovariability of plasma adiponectin. Clin Chem Lab Med. 2006;44:1264-8.
15. Joshy G, Simmons D. Epidemiology of diabetes in New Zealand: Revisit to a changing landscape. N Z Med J. 2006;119(1235). http://www.nzma.org.nz/joumal/l19-1235/1999
16. Simmons D. The epidemiology of diabetes and its complications in New Zealand. Diabet Med. 1996;13:371-5.
17. Simmons D, Thompson CF, Volklander D. Polynesians: Prone to obesity and Type 2 diabetes mellitus but not hyperinsulinaemia. Diabet Med. 2001;18:193-8.
18. Valsamakis G, Chetty R, McTeman PG, et al. Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol. Diabetes Obes Metab. 2003;5:131-5.
19. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487-95.
20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in. Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97,
21. The expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2000;23 suppl.23:S4-S19.
22. 2001 Census of population and dwellings. Wellington, Statisti6s New Zealand.
23. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without any use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-509.
24. Comuzzie AG, Funahashi, T, Sonnenberg G, et al. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab. 2001;86: 4321-5.
25. Vasseur F, Helbecque N, Dina C, et al. Single nucleotide polymorphism haplotypes in both the proximal promoter and exon 3 of APMl gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Human Molecular Genetics. 2002; 11:2607-14.
26. Vasseur F, Leprêtre F, Lacquemant C, Froguel P. The genetics of adiponectin. Curr Diabetes Rep. 2003; 3:151-8.
27. Hara K, Boutin P, Mori Y, et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes. 2002;51:536-40.
28. Populaire C, Mori Y, Dina C, et al. Does the -11377 promoter variant of APM1 gene contribute to the genetic risk of T2DM in Japanese families? Diabetologia. 2003;46:443-5.
29. Menzaghi C, Ercolino T, Di Paola R, et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes. 2002;51:2306-12.
30. Stumvoll M, Tschritter O, Fritsche A, et al. Association of the T-C polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: Interaction with family history of type 2 diabetes. Diabetes. 2002;51:37-41.
31. Retnakaran R, Hanley AJG, Connelly PW, et al. Low serum levels of high-molecular weight adiponectin in Indo-Asian women during pregnancy. Diabetes Care. 2006;29:1377-79.
32. Miyazaki T, Shimada K, Mokun.H, Daida H. Adipocyte derived plasma protein, adiponectin,is associated with smoking status in patients with coronary heart disease. Heart. 2003;89:663.
33. Thamer C, Stefan N, Stumvoll M, et al. Reduced adiponectin serum levels in smokers. Atherosclerosis. 2005;179:412-22.
34. Barnett R, Moon G, Kearns R. Social inequality and edmic differences in smoking in New Zealand. Soc Sci Med. 2004;59:129-43.
35. Harris EK, Yasaka K. On the calculation of a "reference change" for comparing two consecutive measurements. Clin Chem. 1983; 29:25-30.